GUBBA PHARMA IN E NEWS

CareerLabs partners with Dr Reddy’s for chemical engineering certification programme

September 22, 2021 Gubba Pharma In E News

CareerLabs, Bengaluru-based EdTechstartup, has announced a brand new industry certification programme for chemical engineers in partnership with Dr. Reddy’s Laboratories. The partnership aims at opening...

Continue Reading

Gland Pharma adopts 27 animals at Nehru Zoological Park

September 22, 2021 Gubba Pharma In E News

Gland Pharma, a city-based company has adopted 27 animals in Hyderabad for one year at a cost of Rs 20 lakh. The adopted animals included...

Continue Reading

Biocon Biologics, Serum Institute Life Sciences announce strategic alliance

September 22, 2021 Gubba Pharma In E News

The Board of Directors of Biocon Biologics Limited (BBL), a material subsidiary of Biocon Limited, on September 16 approved the merger of Covidshield Technologies Private...

Continue Reading

Terra pharma: A new drugs legislation must keep the pharma sector growing while safeguarding consumer interest

September 15, 2021 Gubba Pharma In E News

GoI’s move to draft a new law for drugs, medical devices, cosmetics and e-pharmacies recognises changing dynamics in the pharmaceutical sector, which the 1940 vintage...

Continue Reading

New biotech JV in Cuba offers scope for Indian pharma firms: Pharmexcil

September 15, 2021 Gubba Pharma In E News

JV designed to attract venture capital for financing clinical trials in underdeveloped markets A new joint venture established in Cuba is offering opportunities to Indian...

Continue Reading

Contract research, the new sunshine sector for pharma companies

September 15, 2021 Gubba Pharma In E News

Challenged by pricing pressure in the US, the world’s largest pharmaceutical market, Indian companies have taken succour from contract research and manufacturing services (CRAMS) for...

Continue Reading

Dr Reddy’s to sell its rights of anti-cancer agent to Citius Pharma

September 8, 2021 Gubba Pharma In E News

Pharma major Dr Reddy’s Laboratories Ltd has entered into a definitive agreement with Citius Pharmaceuticals Inc for the sale of its entire right of investigational...

Continue Reading

Hetero Pharma Receives EUA from DCGI for Tocilizumab Production

September 8, 2021 Gubba Pharma In E News

Hetero, a globally renowned vertically integrated pharmaceutical organisation announced that the Drug Controller General of India (DCGI) has issued Emergency Use Authorisation (EUA) for the...

Continue Reading

Costly active pharma ingredients from China create healthcare hurdles in India

September 8, 2021 Gubba Pharma In E News

A steep 50 per cent rise in the prices of active pharmaceutical ingredients (API) has raised doubts on the shortage of essential drugs required to...

Continue Reading